Premium
SAFETY OF SAME DAY HD‐MTX WITH INDUCTION THERAPY FOR DLBCL WITH CONCURRENT CNS DISEASE OR AS PROPHYLAXIS FOR HIGH RISK OF CNS RELAPSE
Author(s) -
Barlow B.,
Bodine C. D.,
Hatic H.,
Goyal G.,
Mehta A.,
Narkhede M.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.47_2881
Subject(s) - medicine , vincristine , methotrexate , oncology , rituximab , chemotherapy , mucositis , international prognostic index , cyclophosphamide , prednisone , retrospective cohort study , gastroenterology , etoposide , surgery , lymphoma